Inceptionr LLC Makes New Investment in Xylem Inc. $XYL

Inceptionr LLC purchased a new stake in shares of Xylem Inc. (NYSE:XYL) in the first quarter, HoldingsChannel reports. The institutional investor purchased 8,145 shares of the industrial products company’s stock, valued at approximately $973,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in XYL. J. Stern & Co. LLP lifted its stake in shares of Xylem by 12,326.6% in the 4th quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock worth $6,189,132,000 after purchasing an additional 45,082,435 shares during the period. Norges Bank bought a new stake in Xylem during the fourth quarter valued at approximately $361,012,000. SEB Asset Management AB bought a new stake in Xylem during the first quarter valued at approximately $66,700,000. Balyasny Asset Management L.P. increased its holdings in Xylem by 346.2% during the third quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company’s stock valued at $105,160,000 after buying an additional 553,152 shares during the last quarter. Finally, Adage Capital Partners GP L.L.C. purchased a new stake in Xylem during the second quarter valued at approximately $64,407,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. JPMorgan Chase & Co. dropped their price target on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, April 16th. Jefferies Financial Group upgraded Xylem from a “hold” rating to a “buy” rating and upped their price objective for the stock from $130.00 to $140.00 in a research note on Thursday, June 25th. Oppenheimer decreased their target price on Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a report on Wednesday, April 29th. CLSA upgraded Xylem to a “hold” rating in a research report on Thursday, June 25th. Finally, Royal Bank Of Canada lifted their target price on Xylem from $157.00 to $159.00 and gave the company an “outperform” rating in a research report on Thursday, July 16th. Eight equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $153.15.

Insider Buying and Selling at Xylem

In other news, CAO Geri-Michelle Mcshane sold 4,269 shares of the business’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the transaction, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jerome A. Peribere acquired 1,210 shares of the stock in a transaction dated Monday, May 4th. The stock was acquired at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the transaction, the director directly owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. This represents a 4.65% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.32% of the company’s stock.

Xylem Price Performance

Shares of NYSE:XYL opened at $119.66 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10. Xylem Inc. has a 1-year low of $105.29 and a 1-year high of $154.27. The company has a market capitalization of $28.44 billion, a P/E ratio of 29.77, a P/E/G ratio of 1.66 and a beta of 1.03. The firm’s 50 day simple moving average is $114.04 and its two-hundred day simple moving average is $122.82.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. The business had revenue of $2.12 billion during the quarter, compared to analyst estimates of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The company’s revenue was up 2.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.03 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Research analysts expect that Xylem Inc. will post 5.52 EPS for the current fiscal year.

Xylem Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were issued a $0.43 dividend. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $1.72 annualized dividend and a yield of 1.4%. Xylem’s dividend payout ratio is currently 42.79%.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.